Back to Directory

Carly Hoffmann

Email

hoffmann@frontierscience.org

Phone

716-834-0900 x7396

Institution

Frontier Science Foundation

Address

Frontier Science Foundation
4033 Maple Road
Amherst, NY 14226
USA

Request an Update

Affiliated Studies

IMPAACT 2039A: EXCEED

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

IMPAACT 2046: UPLIFT Study

DAIDS Number

Research Area

Brain and Mental Health

Study Status

IMPAACT 2038: Phase I Study of the Infectivity, Safety, and Immunogenicity of a Single Dose of Recombinant, Live-Attenuated, Bovine/Human, Parainfluenza Virus Type 3 (B/HPIV3) Vector Vaccines B/HPIV3/RSV/PreF, B/HPIV3/RSV/PreF/TM, or Placebo, Delivered via Nasal Sprayer to HPIV3-Seronegative Children 6 to 24 Months of Age

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

IMPAACT 2039: EXCEED

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

Show All